Treatment of chronic hepatitis D virus infection with low and high doses of interferon‐α2a: Utility of polymerase chain reaction in monitoring antiviral response
Antonio Madejón, Teresa Cotonat, Javier Bartolomé, Inmaculada Castillo, Vicente Carreño – 1 June 1994 – We examined the efficacy of decreasing high doses (beginning at 18 MU/day) of interferon‐α2a vs. that of daily low doses (3 MU) in the treatment of chronic hepatitis delta virus infection. Patients treated with 18 MU had a somewhat higher frequency of normalization of serum ALT levels than patients treated with low doses (31% and 12%, respectively, on an intention‐to‐treat basis).